The Morning Ledger: Changes to International Tax Rules Advance

Wall Street Journal (blog) - 50 minutes ago
The expansion comes as regulators...

Brain tissue bank focus of this year's Molly Appeal - 2 days ago
Such successes are possible...

Ice Bucket Challenge: Cold truth is that some great nonprofits get left out

San Jose Mercury News - 3 weeks ago
One project I helped start, the...

Back to school: Classroom, building and administrative changes under way at ...

Pittsburgh Post Gazette - 6 days ago
The reading curriculum will expand...

Lawmakers question CMS policy changes for patients with neurological disabilities

The Ripon Advance - 2 days ago
A bipartisan group of legislators...

Medicare shushes ALS sufferers

Boston Herald - 2 weeks ago
CMS said in a statement that the...

Medicare statement on ALS speech-generating devices

Washington Post - 2 weeks ago
A spokesman for the Centers for...

U.S. Rare Earths Last Chance Mine to be First in the US Since the 1960s to ...

CNNMoney - 5 days ago
Portions of the extracted rare...

Editorial: Ice Bucket Challenge warms hearts, fights ALS

The Journal News | - 4 weeks ago
Pelham Town Supervisor Pete...

Newark parents settle in for boycott

Florida gubernatorial candidate Charlie ... - 2 weeks ago
The students have access to youth...

News via Google. See more news matching 'als expanded access'


Expanded Access

Bringing Research and Patients Together

Our Expanded Access platform is meant to do two things:

  1. Empower patients with access to new treatments that are in clinical research.
  2. Empower further research with clinical data from those patients.

For someone with a quick-killer disease, participating in clinical research may be the only way to access a new medicine that might help him live longer.  He may be willing to accept some uncertainty, considering the alternative.  So for patients, there’s a lot of overlap between treatment exploration and research.

But what about patients who cannot get into clinical trials?  Can they still take part in research and explore investigational treatment?

Yes, they can, but only through what are called Expanded Access programs (EAPs).  These are meant to include a much broader group of patients than traditional clinical trials, sometimes exclusively those patients who don’t meet clinical trial enrollment criteria or who otherwise cannot get into trials.

ALS-ETF is bringing a new kind of Expanded Access to the ALS community, to make a groundbreaking impact in the treatment landscape for patients as well as the research that’s powered by patient data.

Learn more about Expanded Access programs here.

Learn more about our research goals here.